Cutan follicular center lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in the follicular centers of lymph nodes. When it affects the nodes of the axilla and upper limb, it can lead to significant clinical manifestations, including lymphadenopathy and systemic symptoms. Accurate coding with ICD-10 Code C82.64 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code C82.64 specifically denotes cutan follicular center lymphoma localized to the lymph nodes of the axilla and upper limb. This condition arises from the malignant transformation of B-cells, leading to the formation of tumors in the lymphatic system. This code should be utilized in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Cutan follicular center lymphoma, particularly when localized to the axillary and upper limb nodes, is a malignancy that requires prompt medical attention due to its potential for progression and systemic involvement. The condition is primarily caused by genetic mutations leading to uncontrolled B-cell proliferation. Early diagnosis and treatment are crucial for improving patient outcomes.
ICD-10 Code C82.64 plays a vital role in SOAP notes by providing a clear diagnosis that guides clinical assessment and treatment planning. It aids in documenting the patient's symptoms, assessment findings, and treatment strategies, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C82.64 connects subjective patient reports and objective clinical findings to a formal diagnosis of cutan follicular center lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of cutan follicular center lymphoma often necessitates hospitalization for comprehensive treatment and monitoring. Therapeutic approaches may include chemotherapy, radiation therapy, and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.64 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description | 
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. | 
| 77014 | Radiologic guidance for placement of a catheter or needle. | 
| 85025 | Complete blood count with automated differential white blood cell count. | 
| 99214 | Established patient office or other outpatient visit, typically 25 minutes. | 
Common Questions About Using ICD-10 Code C82.64 for Cutan folicl center lymphoma, nodes of axilla and upper limb
What are the common symptoms of cutan follicular center lymphoma?
Common symptoms include painless swelling of lymph nodes, night sweats, unexplained weight loss, and fatigue. Patients may also experience systemic symptoms as the disease progresses.
How is cutan follicular center lymphoma diagnosed?
Diagnosis typically involves a physical examination, imaging studies, and a biopsy of the affected lymph nodes to confirm the presence of malignant B-cells.
What treatment options are available for this condition?
Treatment may include chemotherapy, radiation therapy, and targeted therapies. Supportive care is also essential to manage symptoms and improve quality of life.
Is cutan follicular center lymphoma curable?
While cutan follicular center lymphoma is often manageable, it is generally considered incurable. However, many patients can achieve remission with appropriate treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes